Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ulo Langel

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Molecular Sequence Data

Living Beings

Anatomy

Cell Membrane

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mäe Maarja; Andaloussi Samir El; Lehto Taavi; Langel Ulo
Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Kilk Kalle; Mahlapuu Riina; Soomets Ursel; Langel Ulo
Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
Räägel Helin; Säälik Pille; Hansen Mats; Langel Ulo; Pooga Margus
CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ulo Langel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mäe Maarja; Andaloussi Samir El; Lehto Taavi; Langel Ulo
Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Expert opinion on drug delivery 2009;6(11):1195-205.
2009: Kilk Kalle; Mahlapuu Riina; Soomets Ursel; Langel Ulo
Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
Toxicology 2009;265(3):87-95.
2009: Räägel Helin; Säälik Pille; Hansen Mats; Langel Ulo; Pooga Margus
CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
Journal of controlled release : official journal of the Controlled Release Society 2009;139(2):108-17.
2009: Runesson Johan; Saar Indrek; Lundström Linda; Järv Jaak; Langel Ulo
A novel GalR2-specific peptide agonist.
Neuropeptides 2009;43(3):187-92.
2009: Mäe Maarja; El Andaloussi Samir; Lundin Per; Oskolkov Nikita; Johansson Henrik J; Guterstam Peter; Langel Ulo
A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
Journal of controlled release : official journal of the Controlled Release Society 2009;134(3):221-7.
2008: Lundin Per; Johansson Henrik; Guterstam Peter; Holm Tina; Hansen Mats; Langel Ulo; EL Andaloussi Samir
Distinct uptake routes of cell-penetrating peptide conjugates.
Bioconjugate chemistry 2008;19(12):2535-42.
2008: Arsov Zoran; Nemec Marjana; Schara Milan; Johansson Henrik; Langel Ulo; Zorko Matjaz
Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes.
Journal of peptide science : an official publication of the European Peptide Society 2008;14(12):1303-8.
2008: Vukojevic Vladana; Ming Yu; D'Addario Claudio; Hansen Mats; Langel Ulo; Schulz Rüdiger; Johansson Björn; Rigler Rudolf; Terenius Lars
Mu-opioid receptor activation in live cells.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(10):3537-48.
2008: Kuteeva Eugenia; Wardi Tara; Lundström Linda; Sollenberg Ulla; Langel Ulo; Hökfelt Tomas; Ogren Sven Ove
Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(11):2573-85.
2008: Arrighi Romanico B G; Ebikeme Charles; Jiang Yang; Ranford-Cartwright Lisa; Barrett Michael P; Langel Ulo; Faye Ingrid
Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.
Antimicrobial agents and chemotherapy 2008;52(9):3414-7.
2008: Fuxe K; Marcellino D; Rivera A; Diaz-Cabiale Z; Filip M; Gago B; Roberts D C S; Langel U; Genedani S; Ferraro L; de la Calle A; Narvaez J; Tanganelli S; Woods A; Agnati L F
Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.
Brain research reviews 2008;58(2):415-52.
2008: Löfgren Kajsa; Wahlström Anna; Lundberg Pontus; Langel Ulo; Gräslund Astrid; Bedecs Katarina
Antiprion properties of prion protein-derived cell-penetrating peptides.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(7):2177-84.
2008: Hawes Jessica J; Brunzell Darlene H; Narasimhaiah Roopashree; Langel Ulo; Wynick David; Picciotto Marina R
Galanin protects against behavioral and neurochemical correlates of opiate reward.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(8):1864-73.
2008: Alier Kwai A; Chen Yishen; Sollenberg Ulla E; Langel Ulo; Smith Peter A
Selective stimulation of GalR1 and GalR2 in rat substantia gelatinosa reveals a cellular basis for the anti- and pro-nociceptive actions of galanin.
Pain 2008;137(1):138-46.
2008: Guterstam Peter; Lindgren Maria; Johansson Henrik; Tedebark Ulf; Wengel Jesper; El Andaloussi Samir; Langel Ulo
Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.
The Biochemical journal 2008;412(2):307-13.
2008: Holmström Tim H; Mialon Antoine; Kallio Marko; Nymalm Yvonne; Mannermaa Leni; Holm Tina; Johansson Henrik; Black Elizabeth; Gillespie David; Salminen Tiina A; Langel Ulo; Valdez Benigno C; Westermarck Jukka
c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21.
The Journal of biological chemistry 2008;283(11):7046-53.
2008: Hansen Mats; Kilk Kalle; Langel Ulo
Predicting cell-penetrating peptides.
Advanced drug delivery reviews 2008;60(4-5):572-9.
2008: Myrberg Helena; Zhang Lianglin; Mäe Maarja; Langel Ulo
Design of a tumor-homing cell-penetrating peptide.
Bioconjugate chemistry 2008;19(1):70-5.
2008: Johansson Henrik J; El-Andaloussi Samir; Holm Tina; Mäe Maarja; Jänes Jaak; Maimets Toivo; Langel Ulo
Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(1):115-23.
2008: Oglecka Kamila; Lundberg Pontus; Magzoub Mazin; Göran Eriksson L E; Langel Ulo; Gräslund Astrid
Relevance of the N-terminal NLS-like sequence of the prion protein for membrane perturbation effects.
Biochimica et biophysica acta 2008;1778(1):206-13.
2007: Lundström Linda; Sollenberg Ulla E; Bartfai Tamas; Langel Ulo
Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions.
Journal of neurochemistry 2007;103(5):1774-84.
2007: El-Andaloussi Samir; Järver Peter; Johansson Henrik J; Langel Ulo
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
The Biochemical journal 2007;407(2):285-92.
2007: El-Andaloussi Samir; Johansson Henrik J; Holm Tina; Langel Ulo
A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(10):1820-6.
2007: Lundberg Pontus; El-Andaloussi S; Sütlü T; Johansson H; Langel U
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(11):2664-71.
2007: Järver P; Langel K; El-Andaloussi S; Langel U
Applications of cell-penetrating peptides in regulation of gene expression.
Biochemical Society transactions 2007;35(Pt 4):770-4.
2007: Ehrlich Kersti; Viirlaid Säde; Mahlapuu Riina; Saar Külliki; Kullisaar Tiiu; Zilmer Mihkel; Langel Ulo; Soomets Ursel
Design, synthesis and properties of novel powerful antioxidants, glutathione analogues.
Free radical research 2007;41(7):779-87.
2007: Bárány-Wallje Elsa; Gaur Jugnu; Lundberg Pontus; Langel Ulo; Gräslund Astrid
Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo.
FEBS letters 2007;581(13):2389-93.
2007: Blackshear Alice; Yamamoto Mihoko; Anderson Brenda J; Holmes Philip V; Lundström Linda; Langel Ulo; Robinson John K
Intracerebroventricular administration of galanin or galanin receptor subtype 1 agonist M617 induces c-Fos activation in central amygdala and dorsomedial hypothalamus.
Peptides 2007;28(5):1120-4.
2007: Yandek Lindsay E; Pokorny Antje; Florén Anders; Knoelke Kristina; Langel Ulo; Almeida Paulo F F
Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers.
Biophysical journal 2007;92(7):2434-44.
2007: Bavec Aljosa; Jiang Yang; Langel Ulo; Zorko Matjaz
Role of cysteine 341 and arginine 348 of GLP-1 receptor in G-protein coupling.
Molecular biology reports 2007;34(1):53-60.
2007: Myrberg Helena; Lindgren Maria; Langel Ulo
Protein delivery by the cell-penetrating peptide YTA2.
Bioconjugate chemistry 2007;18(1):170-4.
2007: Fisher Linda; Samuelsson Malin; Jiang Yang; Ramberg Veronica; Figueroa Ricardo; Hallberg Einar; Langel Ulo; Iverfeldt Kerstin
Targeting cytokine expression in glial cells by cellular delivery of an NF-kappaB decoy.
Journal of molecular neuroscience : MN 2007;31(3):209-19.
2007: El Andaloussi Samir; Guterstam Peter; Langel Ulo
Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
Nature protocols 2007;2(8):2043-7.
2006: El-Andaloussi Samir; Johansson Henrik J; Lundberg Pontus; Langel Ulo
Induction of splice correction by cell-penetrating peptide nucleic acids.
The journal of gene medicine 2006;8(10):1262-73.
2006: Mäe Maarja; Langel Ulo
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
Current opinion in pharmacology 2006;6(5):509-14.
2006: Jimenez-Andrade Juan Miguel; Lundström Linda; Sollenberg Ulla E; Langel Ulo; Castañeda-Hernandez Gilberto; Carlton Susan M
Activation of peripheral galanin receptors: differential effects on nociception.
Pharmacology, biochemistry, and behavior 2006;85(1):273-80.
2006: Magzoub Mazin; Sandgren Staffan; Lundberg Pontus; Oglecka Kamila; Lilja Johanna; Wittrup Anders; Göran Eriksson L E; Langel Ulo; Belting Mattias; Gräslund Astrid
N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis.
Biochemical and biophysical research communications 2006;348(2):379-85.
2006: Mazarati Andréy; Lundström Linda; Sollenberg Ulla; Shin Don; Langel Ulo; Sankar Raman
Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: The effects of subtype-selective agonists and the role of G-protein-mediated signaling.
The Journal of pharmacology and experimental therapeutics 2006;318(2):700-8.
2006: Elmquist Anna; Hansen Mats; Langel Ulo
Structure-activity relationship study of the cell-penetrating peptide pVEC.
Biochimica et biophysica acta 2006;1758(6):721-9.
2006: Järver Peter; Langel Ulo
Cell-penetrating peptides--a brief introduction.
Biochimica et biophysica acta 2006;1758(3):260-3.
2006: Lindgren Maria; Rosenthal-Aizman Katri; Saar Külliki; Eiríksdóttir Emelía; Jiang Yang; Sassian Meeri; Ostlund Pernilla; Hällbrink Mattias; Langel Ulo
Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.
Biochemical pharmacology 2006;71(4):416-25.
2006: Zielinski Jennifer; Kilk Kalle; Peritz Tiina; Kannanayakal Theresa; Miyashiro Kevin Y; Eiríksdóttir Emelía; Jochems Jeanine; Langel Ulo; Eberwine James
In vivo identification of ribonucleoprotein-RNA interactions.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(5):1557-62.
2006: Holm Tina; Johansson Henrik; Lundberg Pontus; Pooga Margus; Lindgren Maria; Langel Ulo
Studying the uptake of cell-penetrating peptides.
Nature protocols 2006;1(2):1001-5.
2006: Zeng Fanyi; Peritz Tiina; Kannanayakal Theresa J; Kilk Kalle; Eiríksdóttir Emelía; Langel Ulo; Eberwine James
A protocol for PAIR: PNA-assisted identification of RNA binding proteins in living cells.
Nature protocols 2006;1(2):920-7.
2006: Peritz Tiina; Zeng Fanyi; Kannanayakal Theresa J; Kilk Kalle; Eiríksdóttir Emelía; Langel Ulo; Eberwine James
Immunoprecipitation of mRNA-protein complexes.
Nature protocols 2006;1(2):577-80.
2005: Florén Anders; Sollenberg Ulla; Lundström Linda; Zorko Matjaz; Stojan Jure; Budihna Metka; Wheatley Mark; Martin Negin P; Kilk Kalle; Mazarati Andrey; Bartfai Tamas; Lindgren Maria; Langel Ulo
Multiple interaction sites of galnon trigger its biological effects.
Neuropeptides 2005;39(6):547-58.
2005: El-Andaloussi S; Johansson H; Magnusdottir A; Järver P; Lundberg P; Langel Ulo
TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein.
Journal of controlled release : official journal of the Controlled Release Society 2005;110(1):189-201.
2005: Sato Masaaki; Hutchinson Dana S; Bengtsson Tore; Floren Anders; Langel Ulo; Horinouchi Takahiro; Evans Bronwyn A; Summers Roger J
Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling.
The Journal of pharmacology and experimental therapeutics 2005;315(3):1354-61.
2005: Padari Kärt; Säälik Pille; Hansen Mats; Koppel Kaida; Raid Raivo; Langel Ulo; Pooga Margus
Cell transduction pathways of transportans.
Bioconjugate chemistry 2005;16(6):1399-410.
2005: Saar Külliki; Lindgren Maria; Hansen Mats; Eiríksdóttir Emelía; Jiang Yang; Rosenthal-Aizman Katri; Sassian Meeri; Langel Ulo
Cell-penetrating peptides: a comparative membrane toxicity study.
Analytical biochemistry 2005;345(1):55-65.
2005: Holm Tina; Netzereab Semharai; Hansen Mats; Langel Ulo; Hällbrink Mattias
Uptake of cell-penetrating peptides in yeasts.
FEBS letters 2005;579(23):5217-22.
2005: Parenteau Julie; Klinck Roscoe; Good Liam; Langel Ulo; Wellinger Raymund J; Elela Sherif Abou
Free uptake of cell-penetrating peptides by fission yeast.
FEBS letters 2005;579(21):4873-8.
2005: Marinova Zoya; Vukojevic Vladana; Surcheva Slavina; Yakovleva Tatiana; Cebers Gvido; Pasikova Natalia; Usynin Ivan; Hugonin Loïc; Fang Weijie; Hallberg Mathias; Hirschberg Daniel; Bergman Tomas; Langel Ulo; Hauser Kurt F; Pramanik Aladdin; Aldrich Jane V; Gräslund Astrid; Terenius Lars; Bakalkin Georgy
Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission.
The Journal of biological chemistry 2005;280(28):26360-70.
2005: Brewer Ariel; Echevarria David J; Langel Ulo; Robinson John K
Assessment of new functional roles for galanin in the CNS.
Neuropeptides 2005;39(3):323-6.
2005: Lundström Linda; Lu Xiaoying; Langel Ulo; Bartfai Tamas
Important pharmacophores for binding to galanin receptor 2.
Neuropeptides 2005;39(3):169-71.
2005: Sollenberg Ulla; Bartfai Tamas; Langel Ulo
Galnon--a low-molecular weight ligand of the galanin receptors.
Neuropeptides 2005;39(3):161-3.
2005: Lu Xiaoying; Lundström Linda; Langel Ulo; Bartfai Tamas
Galanin receptor ligands.
Neuropeptides 2005;39(3):143-6.
2005: Ståhl Annelie; Nilsson Stefan; Lundberg Pontus; Bhushan Shashi; Biverståhl Henrik; Moberg Per; Morisset Magali; Vener Alexander; Mäler Lena; Langel Ulo; Glaser Elzbieta
Two novel targeting peptide degrading proteases, PrePs, in mitochondria and chloroplasts, so similar and still different.
Journal of molecular biology 2005;349(4):847-60.
2005: Mäe Maarja; Myrberg Helena; Jiang Yang; Paves Heiti; Valkna Andres; Langel Ulo
Internalisation of cell-penetrating peptides into tobacco protoplasts.
Biochimica et biophysica acta 2005;1669(2):101-7.
2005: Echevarria David J; Brewer Ariel; Bushell Georgia; Manuzon Honeyleen; Langel Ulo; Robinson John K
Galanin and perseveration.
Brain research 2005;1041(2):143-8.
2005: Brewer Ariel; Langel Ulo; Robinson John K
Intracerebroventricular administration of galanin decreases free water intake and operant water reinforcer efficacy in water-restricted rats.
Neuropeptides 2005;39(2):117-24.
2005: Kilk Kalle; El-Andaloussi Samir; Järver Peter; Meikas Anne; Valkna Andres; Bartfai Tamas; Kogerman Priit; Metsis Madis; Langel Ulo
Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
Journal of controlled release : official journal of the Controlled Release Society 2005;103(2):511-23.
2005: Quynh Nguyen Thi Thu; Islam Md Shahidul; Florén Anders; Bartfai Tamas; Langel Ulo; Ostenson Claes-Göran
Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets.
Biochemical and biophysical research communications 2005;328(1):213-20.
2005: Zorko Matjaz; Langel Ulo
Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
Advanced drug delivery reviews 2005;57(4):529-45.
2005: El-Andaloussi S; Holm T; Langel Ulo
Cell-penetrating peptides: mechanisms and applications.
Current pharmaceutical design 2005;11(28):3597-611.
2005: Lundström Linda; Elmquist Anna; Bartfai Tamas; Langel Ulo
Galanin and its receptors in neurological disorders.
Neuromolecular medicine 2005;7(1-2):157-80.
2005: Soomets Ursel; Zilmer Mihkel; Langel Ulo
Manual solid-phase synthesis of glutathione analogs: a laboratory-based short course.
Methods in molecular biology (Clifton, N.J.) 2005;298():241-57.
2005: Kilk Kalle; Langel Ulo
Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
Methods in molecular biology (Clifton, N.J.) 2005;298():131-41.
2005: Pooga Margus; Langel Ulo
Synthesis of cell-penetrating peptides for cargo delivery.
Methods in molecular biology (Clifton, N.J.) 2005;298():77-89.
2004: Säälik Pille; Elmquist Anna; Hansen Mats; Padari Kärt; Saar Külliki; Viht Kaido; Langel Ulo; Pooga Margus
Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
Bioconjugate chemistry 2004;15(6):1246-53.
2004: Põder P; Zilmer M; Starkopf J; Kals J; Talonpoika A; Pulges A; Langel U; Kullisaar T; Viirlaid S; Mahlapuu R; Zarkovski A; Arend A; Soomets U
An antioxidant tetrapeptide UPF1 in rats has a neuroprotective effect in transient global brain ischemia.
Neuroscience letters 2004;370(1):45-50.
2004: Brewer Ariel; Langel Ulo; Robinson John K
Intracerebroventricularly administered galanin does not alter operant reaction time or differentially reinforced high rate schedule operant responding in rats.
Neuroscience letters 2004;369(3):245-9.
2004: Kilk Kalle; Elmquist Anna; Saar Külliki; Pooga Margus; Land Tiit; Bartfai Tamas; Soomets Ursel; Langel Ulo
Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.
Neuropeptides 2004;38(5):316-24.
2004: Fisher L; Soomets U; Cortés Toro V; Chilton L; Jiang Y; Langel U; Iverfeldt K
Cellular delivery of a double-stranded oligonucleotide NFkappaB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide.
Gene therapy 2004;11(16):1264-72.
2004: Mazarati Andrey; Lu Xiaoying; Kilk Kalle; Langel Ulo; Wasterlain Claude; Bartfai Tamas
Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus.
The European journal of neuroscience 2004;19(12):3235-44.
2004: Järver Peter; Langel Ulo
The use of cell-penetrating peptides as a tool for gene regulation.
Drug discovery today 2004;9(9):395-402.
2004: Abramov Urho; Florén Anders; Echevarria David J; Brewer Ariel; Manuzon Honeyleen; Robinson John K; Bartfai Tamas; Vasar Eero; Langel Ulo
Regulation of feeding by galnon.
Neuropeptides 2004;38(1):55-61.
2004: Nekhotiaeva Natalia; Elmquist Anna; Rajarao Gunaratna Kuttuva; Hällbrink Mattias; Langel Ulo; Good Liam
Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(2):394-6.
2004: Hua Xiao-Ying; Hayes Carol S; Hofer Anthony; Fitzsimmons Bethany; Kilk Kalle; Langel Ulo; Bartfai Tamas; Yaksh Tony L
Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
The Journal of pharmacology and experimental therapeutics 2004;308(2):574-82.
2004: Lindgren Maria E; Hällbrink Mattias M; Elmquist Anna M; Langel Ulo
Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
The Biochemical journal 2004;377(Pt 1):69-76.
2003: Wu Wei-Ping; Hao Jing-Xia; Lundström Linda; Wiesenfeld-Hallin Zsuzsanna; Langel Ulo; Bartfai Tamas; Xu Xiao-Jun
Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury.
European journal of pharmacology 2003;482(1-3):133-7.
2003: Lundberg Pontus; Langel Ulo
A brief introduction to cell-penetrating peptides.
Journal of molecular recognition : JMR 2003;16(5):227-33.
2003: Mahlapuu Riina; Viht Kaido; Balaspiri Lajos; Bogdanovic Nenad; Saar Külliki; Soomets Ursel; Land Tiit; Zilmer Mihkel; Karelson Ello; Langel Ulo
Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain.
Brain research. Molecular brain research 2003;117(1):73-82.
2003: Zachariou Venetia; Brunzell Darlene H; Hawes Jessica; Stedman Diann R; Bartfai Tamas; Steiner Robert A; Wynick David; Langel Ulo; Picciotto Marina R
The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(15):9028-33.
2003: Elmquist Anna; Langel Ulo
In vitro uptake and stability study of pVEC and its all-D analog.
Biological chemistry 2003;384(3):387-93.
2003: Bavec Aljosa; Hällbrink Mattias; Langel Ulo; Zorko Matjaz
Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling.
Regulatory peptides 2003;111(1-3):137-44.
2003: Howitt Stephen G; Kilk Kalle; Wang Yang; Smith David M; Langel Ulo; Poyner David R
The role of the 8-18 helix of CGRP8-37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions.
British journal of pharmacology 2003;138(2):325-32.
2003: Adlerz Linda; Soomets Ursel; Holmlund Linda; Viirlaid Säde; Langel Ulo; Iverfeldt Kerstin
Down-regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes.
Neuroscience letters 2003;336(1):55-9.
2002: Karelson E; Mahlapuu R; Zilmer M; Soomets U; Bogdanovic N; Langel U
Possible signaling by glutathione and its novel analogue through potent stimulation of fontocortical G proteins in normal aging and in Alzheimer's disease.
Annals of the New York Academy of Sciences 2002;973():537-40.
2002: Lundberg P; Magzoub M; Lindberg M; Hällbrink M; Jarvet J; Eriksson L E G; Langel U; Gräslund A
Cell membrane translocation of the N-terminal (1-28) part of the prion protein.
Biochemical and biophysical research communications 2002;299(1):85-90.
2002: Conner A C; Hay D L; Howitt S G; Kilk K; Langel U; Wheatley M; Smith D M; Poyner D R
Interaction of calcitonin-gene-related peptide with its receptors.
Biochemical Society transactions 2002;30(4):451-5.
2002: Saar Külliki; Mazarati Andrey M; Mahlapuu Riina; Hallnemo Gerd; Soomets Ursel; Kilk Kalle; Hellberg Sven; Pooga Margus; Tolf Bo-Ragnar; Shi Tiejun S; Hökfelt Tomas; Wasterlain Claude; Bartfai Tamas; Langel Ulo
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):7136-41.
2002: Suzuki Hironobu; Iwanaga Toshihiko; Yoshie Hiromasa; Li Jun; Yamabe Kaoru; Yanaihara Noboru; Langel Ulo; Maeda Takeyasu
Expression of galanin receptor-1 (GALR1) in the rat trigeminal ganglia and molar teeth.
Neuroscience research 2002;42(3):197-207.
2002: Ostenson Claes-Göran; Sandberg-Nordqvist Ann-Christine; Chen Jie; Hällbrink Mattias; Rotin Daniela; Langel Ulo; Efendic Suad
Overexpression of protein-tyrosine phosphatase PTP sigma is linked to impaired glucose-induced insulin secretion in hereditary diabetic Goto-Kakizaki rats.
Biochemical and biophysical research communications 2002;291(4):945-50.
2002: Farquhar Michelle; Soomets Ursel; Bates Ruth L; Martin Ashley; Langel Ulo; Howl John
Novel mastoparan analogs induce differential secretion from mast cells.
Chemistry & biology 2002;9(1):63-70.
2002: Pooga Margus; Soomets Ursel; Bartfai Tamas; Langel Ulo
Synthesis of cell-penetrating peptide-PNA constructs.
Methods in molecular biology (Clifton, N.J.) 2002;208():225-36.
2001: Toro V C; Tehranian R; Zetterström M; Eriksson G; Langel U; Bartfai T; Iverfeld K
Increased gene expression of interleukin-1alpha and interleukin-6 in rat primary glial cells induced by beta-amyloid fragment.
Journal of molecular neuroscience : MN 2001;17(3):341-50.
2001: Mazarati A; Langel U; Bartfai T
Galanin: an endogenous anticonvulsant?
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2001;7(6):506-17.
2001: Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
Cargo delivery kinetics of cell-penetrating peptides.
Biochimica et biophysica acta 2001;1515(2):101-9.
2001: Kilk K; Magzoub M; Pooga M; Eriksson L E; Langel U; Gräslund A
Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide.
Bioconjugate chemistry 2001;12(6):911-6.
2001: Pooga M; Kut C; Kihlmark M; Hällbrink M; Fernaeus S; Raid R; Land T; Hallberg E; Bartfai T; Langel U
Cellular translocation of proteins by transportan.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(8):1451-3.
2001: Pooga M; Land T; Bartfai T; Langel U
PNA oligomers as tools for specific modulation of gene expression.
Biomolecular engineering 2001;17(6):183-92.
2001: Magzoub M; Kilk K; Eriksson L E; Langel U; Gräslund A
Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles.
Biochimica et biophysica acta 2001;1512(1):77-89.
2001: Yakovleva T; Pramanik A; Kawasaki T; Tan-No K; Gileva I; Lindegren H; Langel U; Ekstrom T J; Rigler R; Terenius L; Bakalkin G
p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.
The Journal of biological chemistry 2001;276(19):15650-8.
2001: Lindberg M; Jarvet J; Langel U; Gräslund A
Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR.
Biochemistry 2001;40(10):3141-9.
2001: Hällbrink M; Holmqvist T; Olsson M; Ostenson C G; Efendic S; Langel U
Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Galpha(s) and Galpha(i)/Galpha(o) activation.
Biochimica et biophysica acta 2001;1546(1):79-86.
2001: Rezaei K; Xu I S; Wu W P; Shi T J; Soomets U; Land T; Xu X J; Wiesenfeld-Hallin Z; Hökfelt T; Bartfai T; Langel U
Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord.
Neuroreport 2001;12(2):317-20.
2001: Baláspiri L; Langel U
Synthesis of of beta-amyloid precursor peptide and presenilin segments.
Journal of peptide science : an official publication of the European Peptide Society 2001;7(1):58-60.
2000: Lindgren M; Gallet X; Soomets U; Hällbrink M; Bråkenhielm E; Pooga M; Brasseur R; Langel U
Translocation properties of novel cell penetrating transportan and penetratin analogues.
Bioconjugate chemistry 2000;11(5):619-26.
2000: Soomets U; Lindgren M; Gallet X; Hällbrink M; Elmquist A; Balaspiri L; Zorko M; Pooga M; Brasseur R; Langel U
Deletion analogues of transportan.
Biochimica et biophysica acta 2000;1467(1):165-76.
2000: Lindgren M; Hällbrink M; Prochiantz A; Langel U
Cell-penetrating peptides.
Trends in pharmacological sciences 2000;21(3):99-103.
2000: Rezaei K; Saar K; Soomets U; Valkna A; Näsman J; Zorko M; Akerman K; Schroeder T; Bartfai T; Langel U
Role of third intracellular loop of galanin receptor type 1 in signal transduction.
Neuropeptides 2000;34(1):25-31.
2000: Kurg R; Langel U; Ustav M
Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acid.
Virus research 2000;66(1):39-50.
1999: Soomets U; Mahlapuu R; Tehranian R; Jarvet J; Karelson E; Zilmer M; Iverfeldt K; Zorko M; Gräslund A; Langel U
Regulation of GTPase and adenylate cyclase activity by amyloid beta-peptide and its fragments in rat brain tissue.
Brain research 1999;850(1-2):179-88.
1999: Soomets U; Hällbrink M; Langel U
Antisense properties of peptide nucleic acids.
Frontiers in bioscience : a journal and virtual library 1999;4():D782-6.
1999: Hällbrink M; Saar K; Ostenson C G; Soomets U; Efendic S; Howl J; Wheatley M; Zorko M; Langel U
Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity.
Regulatory peptides 1999;82(1-3):45-51.
1999: Kurg R; Parik J; Juronen E; Sedman T; Abroi A; Liiv I; Langel U; Ustav M
Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication.
Journal of virology 1999;73(6):4670-7.
1999: Bavec A; Juréus A; Cigic B; Langel U; Zorko M
Peptitergent PD1 affects the GTPase activity of rat brain cortical membranes.
Peptides 1999;20(2):177-84.
1998: Pooga M; Lindgren M; Hällbrink M; Bråkenhielm E; Langel U
Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities.
Annals of the New York Academy of Sciences 1998;863():450-3.
1998: Langel U; Bartfai T
Chemistry and molecular biology of galanin receptor ligands.
Annals of the New York Academy of Sciences 1998;863():86-93.
1998: Kask K; Berthold M; Kahl U; Juréus A; Nordvall G; Langel U; Bartfai T
Mutagenesis study on human galanin receptor GalR1 reveals domains involved in ligand binding.
Annals of the New York Academy of Sciences 1998;863():78-85.
1998: Mazarati A M; Liu H; Soomets U; Sankar R; Shin D; Katsumori H; Langel U; Wasterlain C G
Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(23):10070-7.
1998: Juréus A; Lindgren M; Langel U; Bartfai T
Purification of a galanin degrading 70 kDa metallo-peptidase from bovine spinal cord.
Neuropeptides 1998;32(5):453-60.
1998: Pooga M; Soomets U; Hällbrink M; Valkna A; Saar K; Rezaei K; Kahl U; Hao J X; Xu X J; Wiesenfeld-Hallin Z; Hökfelt T; Bartfai T; Langel U
Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.
Nature biotechnology 1998;16(9):857-61.
1998: Poyner D R; Soomets U; Howitt S G; Langel U
Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col 29 cells: studies with chimeric and other peptides.
British journal of pharmacology 1998;124(8):1659-66.
1998: Longland C L; Mezna M; Langel U; Hällbrink M; Soomets U; Wheatley M; Michelangeli F; Howl J
Biochemical mechanisms of calcium mobilisation induced by mastoparan and chimeric hormone-mastoparan constructs.
Cell calcium 1998;24(1):27-34.
1998: Karelson E; Langel U
Galaninergic signalling and adenylate cyclase.
Neuropeptides 1998;32(3):197-210.
1998: Ohman A; Lycksell P O; Juréus A; Langel U; Bartfai T; Gräslund A
NMR study of the conformation and localization of porcine galanin in SDS micelles. Comparison with an inactive analog and a galanin receptor antagonist.
Biochemistry 1998;37(25):9169-78.
1998: Pooga M; Juréus A; Razaei K; Hasanvan H; Saar K; Kask K; Kjellén P; Land T; Halonen J; Mäeorg U; Uri A; Solyom S; Bartfai T; Langel U
Novel galanin receptor ligands.
The journal of peptide research : official journal of the American Peptide Society 1998;51(1):65-74.
1998: Zorko M; Pooga M; Saar K; Rezaei K; Langel U
Differential regulation of GTPase activity by mastoparan and galparan.
Archives of biochemistry and biophysics 1998;349(2):321-8.
1998: Pooga M; Hällbrink M; Zorko M; Langel U
Cell penetration by transportan.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1998;12(1):67-77.
1997: Berthold M; Kahl U; Juréus A; Kask K; Nordvall G; Langel U; Bartfai T
Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1.
European journal of biochemistry / FEBS 1997;249(2):601-6.
1997: Mezna M; Langel U; Hällbrink M; Wheatley M; Michelangeli F; Howl J
Calcium-mobilizing actions of chimeric hormone-mastoparan peptides.
Biochemical Society transactions 1997;25(3):450S.
1997: Saar K; Valkna A; Soomets U; Rezaei K; Zorko M; Zilmer M; Langel U
Role of the third cytoplasmic loop in signal transduction by galanin receptors.
Biochemical Society transactions 1997;25(3):1036-40.
1997: Howl J; Langel U; Hawtin S R; Valkna A; Yarwood N J; Saar K; Wheatley M
Chimeric strategies for the rational design of bioactive analogs of small peptide hormones.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1997;11(7):582-90.
1997: Juréus A; Langel U; Bartfai T
L-Ala-substituted rat galanin analogs distinguish between hypothalamic and jejunal galanin receptor subtypes.
The journal of peptide research : official journal of the American Peptide Society 1997;49(3):195-200.
1996: Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
Regulatory peptides 1996;62(2-3):131-6.
1996: Langel U; Pooga M; Kairane C; Zilmer M; Bartfai T
A galanin-mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition by ouabain.
Regulatory peptides 1996;62(1):47-52.
1996: Ohman A; Davydov R; Backlund B M; Langel U; Gräslund A
A study of melittin, motilin and galanin in reversed micellar environments, using circular dichroism spectroscopy.
Biophysical chemistry 1996;59(1-2):185-92.
1995: Kask K; Langel U; Bartfai T
Galanin--a neuropeptide with inhibitory actions.
Cellular and molecular neurobiology 1995;15(6):653-73.
1995: Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
Regulatory peptides 1995;59(3):341-8.
1995: Xu X J; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
New high affinity peptide antagonists to the spinal galanin receptor.
British journal of pharmacology 1995;116(3):2076-80.
1995: Bedecs K; Langel U; Bartfai T
Metabolism of galanin and galanin (1-16) in isolated cerebrospinal fluid and spinal cord membranes from rat.
Neuropeptides 1995;29(3):137-43.
1995: Zetterström M; Trogen L; Hammarström L G; Juhlin L; Nilsson B; Damberg C; Bartfai T; Langel U
Synthesis of an N-methyldehydroalanine-containing fragment of microcystin by combination of solid phase peptide synthesis and beta-elimination in solution.
Acta chemica Scandinavica (Copenhagen, Denmark : 1989) 1995;49(9):696-700.
1995: Ohman A; Lycksell P O; Andell S; Langel U; Bartfai T; Gräslund A
Solvent stabilized solution structures of galanin and galanin analogs, studied by circular dichroism spectroscopy.
Biochimica et biophysica acta 1995;1236(2):259-65.
1995: Xu X J; Andell S; Zhang X; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Hökfelt T; Bartfai T
Peripheral axotomy increases the expression of galanin message-associated peptide (GMAP) in dorsal root ganglion cells and alters the effects of intrathecal GMAP on the flexor reflex in the rat.
Neuropeptides 1995;28(5):299-307.
1995: Valkna A; Juréus A; Karelson E; Zilmer M; Bartfai T; Langel U
Differential regulation of adenylate cyclase activity in rat ventral and dorsal hippocampus by rat galanin.
Neuroscience letters 1995;187(2):75-8.
1994: Gregersen S; Langel U; Bartfai T; Ahrén B
N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets.
Regulatory peptides 1994;53(1):31-7.
1994: Bedecs K; Langel U; Xu X J; Wiesenfeld-Hallin Z; Bartfai T
Biological activities of two endogenously occurring N-terminally extended forms of galanin in the rat spinal cord.
European journal of pharmacology 1994;259(2):151-6.
1994: Arvidsson K; Langel U; Ehrenberg A
Comparison of the solution structures of the chimeric peptides galanin(1-12)-Ala-neuropeptide Y(25-36)amide and galanin(1-12)-Pro-neuropeptide Y(25-36)amide.
European journal of biochemistry / FEBS 1994;222(2):573-81.
1994: Gregersen S; Langel U; Bartfai T; Ahrén B
Galanin message-associated polypeptide (GMAP) does not affect insulin secretion from isolated islets.
European journal of pharmacology 1994;259(1):79-82.
1994: Rivera Baeza C; Kask K; Langel U; Bartfai T; Undén A
Analogs of galanin (1-16) modified in positions 1-3 as ligands to rat hypothalamic galanin receptors.
Acta chemica Scandinavica (Copenhagen, Denmark : 1989) 1994;48(5):434-8.
1994: Kahl U; Langel U; Bartfai T; Grundemar L
Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
British journal of pharmacology 1994;111(4):1129-34.
1993: Bartfai T; Langel U; Bedecs K; Andell S; Land T; Gregersen S; Ahrén B; Girotti P; Consolo S; Corwin R
Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(23):11287-91.
1993: Hulting A L; Land T; Berthold M; Langel U; Hökfelt T; Bartfai T
Galanin receptors from human pituitary tumors assayed with human galanin as ligand.
Brain research 1993;625(1):173-6.
1993: Ogren S O; Pramanik A; Land T; Langel U
Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release.
European journal of pharmacology 1993;242(1):59-64.
1993: Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A
Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors.
Biochemistry 1993;32(30):7787-98.
1993: Girotti P; Bertorelli R; Fisone G; Land T; Langel U; Consolo S; Bartfai T
N-terminal galanin fragments inhibit the hippocampal release of acetylcholine in vivo.
Brain research 1993;612(1-2):258-62.
1993: Gregersen S; Lindskog S; Land T; Langel U; Bartfai T; Ahrén B
Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
European journal of pharmacology 1993;232(1):35-9.
1993: Verge V M; Xu X J; Langel U; Hökfelt T; Wiesenfeld-Hallin Z; Bartfai T
Evidence for endogenous inhibition of autotomy by galanin in the rat after sciatic nerve section: demonstrated by chronic intrathecal infusion of a high affinity galanin receptor antagonist.
Neuroscience letters 1993;149(2):193-7.
1993: Crawley J N; Robinson J K; Langel U; Bartfai T
Galanin receptor antagonists M40 and C7 block galanin-induced feeding.
Brain research 1993;600(2):268-72.
1993: Bartfai T; Hökfelt T; Langel U
Galanin--a neuroendocrine peptide.
Critical reviews in neurobiology 1993;7(3-4):229-74.
1992: Ogren S O; Hökfelt T; Kask K; Langel U; Bartfai T
Evidence for a role of the neuropeptide galanin in spatial learning.
Neuroscience 1992;51(1):1-5.
1992: Bartfai T; Fisone G; Langel U
Galanin and galanin antagonists: molecular and biochemical perspectives.
Trends in pharmacological sciences 1992;13(8):312-7.
1992: Hökfelt T; Aman K; Arvidsson U; Bedecs K; Ceccatelli S; Hulting A L; Langel U; Meister B; Pieribone V; Bartfai T
Galanin message-associated peptide (GMAP)- and galanin-like immunoreactivities: overlapping and differential distributions in the rat.
Neuroscience letters 1992;142(2):139-42.
1992: Langel U; Land T; Bartfai T
Design of chimeric peptide ligands to galanin receptors and substance P receptors.
International journal of peptide and protein research 1992;39(6):516-22.
1992: Wiesenfeld-Hallin Z; Xu X J; Langel U; Bedecs K; Hökfelt T; Bartfai T
Galanin-mediated control of pain: enhanced role after nerve injury.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3334-7.
1992: Bedecs K; Langel U; Bartfai T; Wiesenfeld-Hallin Z
Galanin receptors and their second messengers in the lumbar dorsal spinal cord.
Acta physiologica Scandinavica 1992;144(3):213-20.
1992: Lindskog S; Ahrén B; Land T; Langel U; Bartfai T
The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.
European journal of pharmacology 1992;210(2):183-8.
1992: Laasik J; Sillard R; Langel U; Zilmer M
Lipid-protein interactions in neurotropic Na-pump regulation.
Acta physiologica Scandinavica. Supplementum 1992;607():249-51.
1991: Bartfai T; Bedecs K; Land T; Langel U; Bertorelli R; Girotti P; Consolo S; Xu X J; Wiesenfeld-Hallin Z; Nilsson S
M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10961-5.
1991: Gregersen S; Hermansen K; Langel U; Fisone G; Bartfai T; Ahrén B
Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues.
European journal of pharmacology 1991;203(1):111-4.
1991: Land T; Langel U; Bartfai T
Hypothalamic degradation of galanin(1-29) and galanin(1-16): identification and characterization of the peptidolytic products.
Brain research 1991;558(2):245-50.
1991: Land T; Langel U; Löw M; Berthold M; Undén A; Bartfai T
Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor.
International journal of peptide and protein research 1991;38(3):267-72.
1991: Sillard R; Langel U; Jörnvall H
Isolation and characterization of galanin from sheep brain.
Peptides 1991;12(4):855-9.
1990: Crawley J N; Austin M C; Fiske S M; Martin B; Consolo S; Berthold M; Langel U; Fisone G; Bartfai T
Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1990;10(11):3695-700.
1989: Fisone G; Langel U; Carlquist M; Bergman T; Consolo S; Hökfelt T; Undén A; Andell S; Bartfai T
Galanin receptor and its ligands in the rat hippocampus.
European journal of biochemistry / FEBS 1989;181(1):269-76.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ulo Langel

Research Profile (preview)

Chemicals & Drugs

Genes & Molecular Sequences

Concepts & Ideas

Living Beings

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ulo Langel (preview)

All Publications